Tag: Entrectinib

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Entrectinib

Ignyta, Inc. (RXDX) Analysts See $-0.44 EPS

Added to Collection on: 2018-02-15 00:52:30

Tags for this article:

Economy
NASDAQ
Short
Chemistry
Organic chemistry
Protein kinase inhibitor
Tyrosine kinase receptors
Entrectinib
ROS1
Anaplastic lymphoma kinase
Trk receptor

Click the tags to see associated articles and topics

View Article Details
Is Buying Ignyta Delaware (NASDAQ:RXDX) Here Good Idea?

Added to Collection on: 2018-02-18 20:33:34

Tags for this article:

Money
Finance
Economy
NASDAQ
Stock
Short
Protein kinase inhibitor
Tyrosine kinase receptors
Entrectinib
ROS1
Anaplastic lymphoma kinase
Trk receptor

Click the tags to see associated articles and topics

View Article Details
Roche buys rest of Foundation Medicine in $2.4B bet on targeted cancer treatment

Added to Collection on: 2018-06-19 00:07:30

Tags for this article:

Medicine
Clinical medicine
Cancer
Chemotherapy
Roche Pharmaceuticals
Hoffmann-La Roche
Tyrosine kinase receptors
Entrectinib
ROS1
Anaplastic lymphoma kinase

Click the tags to see associated articles and topics

View Article Details
Joining AI Drug Discovery Race, Erasca Adds $22M For Cancer Work

Added to Collection on: 2019-03-06 02:11:15

Tags for this article:

Health
Artificial intelligence
Oncology
Andreessen Horowitz
Artificial intelligence in healthcare
Celgene
Chemotherapy
Entrectinib
GNS Healthcare
Chemical compounds
Health software
Jonathan Lim

Click the tags to see associated articles and topics

View Article Details
ASCO: Entrectinib gets edge over crizotinib against ROS1+ lung cancer

Added to Collection on: 2019-05-30 00:52:30

Tags for this article:

Clinical trial
Piperidines
Lung cancer
Non-small-cell lung carcinoma
Pyridines
Tyrosine kinase receptors
Entrectinib
ROS1
Crizotinib
Chemical compounds
Organic compounds
Trinidad and Tobago Dollar
Brain metastasis
Robert C. Doebele

Click the tags to see associated articles and topics

View Article Details
Double first for Scotland as it backs Roche's Rozlytrek, Novartis' Zolgensma

Added to Collection on: 2021-03-09 10:52:30

Tags for this article:

Branches of biology
Orphan drugs
Health sciences
Chemical compounds
Breakthrough therapy
Tyrosine kinase receptors
Entrectinib
Piperazines
ROS1
Onasemnogene abeparvovec
Gene therapy
Larotrectinib
Roche Products Ltd.

Click the tags to see associated articles and topics

View Article Details
Innovent's ROS1 TKI closer to winning the Chinese NSCLC market

Added to Collection on: 2024-03-08 19:50:36

Tags for this article:

Tyrosine kinase receptors
Orphan drugs
Tyrosine kinase inhibitors
ROS1
CYP3A4 inhibitors
Lung cancer
Entrectinib
Anaplastic lymphoma kinase
Crizotinib
Non-small-cell lung cancer
Repotrectinib
Amgen
China

Click the tags to see associated articles and topics

View Article Details
Taletrectinib Provides “Prolonged Disease Control” in ROS1+ NSCLC

Added to Collection on: 2025-05-02 19:19:35

Tags for this article:

Tyrosine kinase receptors
ROS1
Tyrosine kinase inhibitors
Lung cancer
CYP3A4 inhibitors
Crizotinib
Non-small-cell lung cancer
Progression-free survival
Entrectinib
Brain metastasis
Clinical endpoint

Click the tags to see associated articles and topics

View Article Details
Book a Demo